Health Care Department Universidad Autónoma Metropolitana Calzada del Hueso 1100, Col Villa Quietud Delg. Coyaoacan, C.P.04960 Ciudad de México
Med Oral Patol Oral Cir Bucal. 2020 May 1;25(3):e388-e394. doi: 10.4317/medoral.23432.
The primordial odontogenic tumor (POT) is a recently described benign entity with histopathological and immunohistochemical features suggesting its origin during early odontogenesis.
To integrate the available data published on POT into a comprehensive analysis to better define its clinicopathological and molecular features.
An electronic systematic review was performed up to September 2019 in multiple databases.
A total of 13 publications were included, representing 16 reported cases and 3 molecular studies. The mean age of the affected patients was 11.6 years (range 2-19), with a slight predominance in males (56.25%). The posterior mandible was the main location (87.5%), with only two cases affecting the posterior maxilla. All cases appeared as a radiolucent lesion in close relationship to an unerupted tooth. Recurrences have not been reported to date. Microscopically, POT comprises fibromyxoid tissue with variable cellularity surrounded by a cuboidal to columnar odontogenic epithelium but without unequivocal dental hard tissue formation. A delicate fibrous capsule surrounds (at least partially) the tumor. The epithelial component shows immunohistochemical positivity for amelogenin, CK19, and CK14, and variable expression of Glut-1, Galectin-3 and Caveolin-1, Vimentin, p-53, PITX2, Bcl-2, Bax and Survivin; the mesenchymal tissue is positive for Vimentin, CD90, p-53, PITX2, Bcl-2, Bax, and Survivin, and the subepithelial region exhibits the strong expression of Syndecan-1 and CD34. The Ki-67 index is low (<5%). The negative or weak expression of dentinogenesis-associated genes could explain the inhibition of dentin and subsequent enamel formation in this neoplasm.
POT is an entity with a well-defined clinicopathological, immunohistochemical and molecular profile that must be properly diagnosed and differentiated from other odontogenic lesions and treated consequently.
原始性牙源性肿瘤(POT)是一种最近描述的良性实体,其组织病理学和免疫组织化学特征提示其起源于早期牙源性发育。
将已发表的关于 POT 的可用数据整合到综合分析中,以更好地定义其临床病理和分子特征。
截至 2019 年 9 月,在多个数据库中进行了电子系统综述。
共纳入 13 篇文献,包括 16 例报道病例和 3 项分子研究。受影响患者的平均年龄为 11.6 岁(范围 2-19 岁),男性略占优势(56.25%)。下颌后区是主要发病部位(87.5%),仅有 2 例发生于上颌后区。所有病例均表现为与未萌出牙密切相关的透亮性病变。迄今为止,尚未报告复发。显微镜下,POT 由纤维粘液样组织组成,细胞数量不等,周围为立方柱状牙源性上皮,但无明确的牙体硬组织形成。一个精细的纤维囊包围着(至少部分)肿瘤。上皮成分免疫组织化学染色阳性,表达角蛋白 19、角蛋白 14 和 Glut-1、Galectin-3 和 Caveolin-1、波形蛋白、p-53、PITX2、Bcl-2、Bax 和 Survivin;间充质组织阳性表达波形蛋白、CD90、p-53、PITX2、Bcl-2、Bax 和 Survivin,上皮下区域表达 Syndecan-1 和 CD34。Ki-67 指数低(<5%)。牙源性基因的阴性或弱表达可能解释了该肿瘤中牙本质形成的抑制以及随后的釉质形成。
POT 是一种具有明确临床病理、免疫组织化学和分子特征的实体,必须正确诊断,并与其他牙源性病变相区分,从而进行相应的治疗。